Pearl's PT010 triple combination provides comparable budesonide exposure to symbicort and comparable glycopyrronium and formoterol exposure to PT003
C. Reisner, C. Fernandez, P. Darken, P. DePetrillo, E. St. Rose, T. Fischer, S. Strom, M. Kong, K. Wong, S. Siddiqui, G. Tardie, C. Orevillo (Morristown, Baltimore, Raleigh, United States Of America; Markham, Canada)
Source: International Congress 2014 – Bronchodilators for asthma and COPD
Session: Bronchodilators for asthma and COPD
Session type: Oral Presentation
Number: 1891
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Reisner, C. Fernandez, P. Darken, P. DePetrillo, E. St. Rose, T. Fischer, S. Strom, M. Kong, K. Wong, S. Siddiqui, G. Tardie, C. Orevillo (Morristown, Baltimore, Raleigh, United States Of America; Markham, Canada). Pearl's PT010 triple combination provides comparable budesonide exposure to symbicort and comparable glycopyrronium and formoterol exposure to PT003. Eur Respir J 2014; 44: Suppl. 58, 1891
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: